CME Group Inc. Files 8-K for Executive and Director Changes

Ticker: CME · Form: 8-K · Filed: 2025-09-11T00:00:00.000Z

Sentiment: neutral

Topics: governance, compensation, board-changes

Related Tickers: CME

TL;DR

CME Group 8-K: Exec & director comp changes, new board members elected.

AI Summary

CME Group Inc. announced on September 9, 2025, changes in its executive and director compensation arrangements. The filing details the departure of a director, the election of new directors, and the appointment of certain officers, alongside updates to their compensatory plans.

Why It Matters

This filing provides insight into the governance and compensation structure of CME Group, which can influence investor confidence and executive decision-making.

Risk Assessment

Risk Level: low — The filing pertains to routine corporate governance and compensation matters, not significant financial distress or operational shifts.

Key Players & Entities

FAQ

What specific items are covered in this Form 8-K filing by CME Group Inc.?

This Form 8-K covers the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.

When was the earliest event reported in this filing?

The earliest event reported in this filing was on September 9, 2025.

What is the exact name of the registrant as specified in its charter?

The exact name of the registrant is CME GROUP INC.

In which state was CME Group Inc. incorporated?

CME Group Inc. was incorporated in Delaware.

What is the IRS Employer Identification Number for CME Group Inc.?

The IRS Employer Identification Number for CME Group Inc. is 36-4459170.

From the Filing

0001156375-25-000190.txt : 20250911 0001156375-25-000190.hdr.sgml : 20250911 20250911120644 ACCESSION NUMBER: 0001156375-25-000190 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20250909 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20250911 DATE AS OF CHANGE: 20250911 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CME GROUP INC. CENTRAL INDEX KEY: 0001156375 STANDARD INDUSTRIAL CLASSIFICATION: SECURITY & COMMODITY BROKERS, DEALERS, EXCHANGES & SERVICES [6200] ORGANIZATION NAME: 09 Crypto Assets EIN: 364459170 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31553 FILM NUMBER: 251307712 BUSINESS ADDRESS: STREET 1: 20 S. WACKER DR. CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: 3129301000 MAIL ADDRESS: STREET 1: 20 S. WACKER DR. CITY: CHICAGO STATE: IL ZIP: 60606 FORMER COMPANY: FORMER CONFORMED NAME: CHICAGO MERCANTILE EXCHANGE HOLDINGS INC DATE OF NAME CHANGE: 20010802 8-K 1 cme-20250909.htm 8-K cme-20250909 false 0001156375 0001156375 2025-09-09 2025-09-09 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549   _________________________________________________________ FORM 8-K   _________________________________________________________ CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) September 11, 2025 ( September 9, 2025 )     _________________________________________________________ CME GROUP INC. (Exact Name of Registrant as Specified in its Charter)   _________________________________________________________   Delaware   001-31553   36-4459170 (State or Other Jurisdiction of Incorporation)   (Commission File No.)   (IRS Employer Identification No.)   20 South Wacker Drive Chicago Illinois   60606 (Address of Principal Executive Offices)   (Zip Code) Registrant’s telephone number, including area code: ( 312 )  930-1000 N/A (Former Name or Former Address, if Changed Since Last Report)   ______________________________________________________ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading symbol Name of each exchange on which registered Class A Common Stock CME Nasdaq Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405) of this chapter or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company   ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 9, 2025, Jack Tobin, the Managing Director and Chief Accounting Officer of CME Group Inc. (the Company) notified the Company of his decision to retire from the Company. Mr. Tob

View on Read The Filing